Log In
Print
BCIQ
Print
Print this Print this
 

MIN-101

  Manage Alerts
Collapse Summary General Information
Company Minoryx Therapeutics S.L.
Description 
Molecular Target Peroxisome proliferation activated receptor (PPAR) gamma
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationLeukodystrophy
Indication DetailsTreat X-linked adrenoleukodystrophy (ALD)
Regulatory Designation EU - Orphan Drug (Treat X-linked adrenoleukodystrophy (ALD))
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today